Discover more near‑term opportunities with better event intelligence.
Fundz combines its own real-time funding and M&A intelligence with executive moves, hiring shifts and other company changes, weighs each signal against your ideal customer profile, and delivers a ranked daily shortlist with the context and decision maker to contact. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
OracleSnowflakeCloudflareLinkedInGoogleSalesforce
★★★★★4.8/5 on G2· Since 2015
Sai Parenterals Limited Appoints Arvind Gannimitta as Chief Operating Officer
PRIVATESep 30, 2026
Position
Chief Operating Officer
Company
SAI Parenterals Limited
Arvind Gannimitta
HyderabadManufacturingBiotechnologyPharmaceutical
Description
Sai Parenterals Limited has made key senior management changes, appointing Arvind Gannimitta as the Chief Operating Officer effective September 30, 2026. The company also appointed Ashwani Singh Bisht as Company Secretary and Compliance Officer during this transition.
Company Information
Company
SAI Parenterals Limited
Location
Hyderabad, Telangana, India
About
SAI Parenterals Limited is a mid-sized pharmaceutical manufacturer specializing in injectable and oral dosage forms. Founded in 2005, the company has been expanding its capabilities and market reach. With a strong focus on regulated markets, SAI is positioning itself as a global player. The company is also preparing for an initial public offering (IPO).
Fundz sees it the moment SAI Parenterals Limited changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
HyderabadManufacturingBiotechnologyPharmaceutical